6th September 2021 | Pharma Updates

Telangana to develop B-Hub as a biopharmaceutical focus

 Hyderabad is a major R&D centre with institutes like IICT, CCMB, CDFD and more than 800 life sciences organizations.

DRL join hands with Citius Pharma

In March 2016, DRL had acquired the exclusive rights (excluding Japan and Asia) to the investigational anti-cancer agent E7777 from Eisai.

Serum Institute paid Rs 3000 crore for 50% stake in SCHOTT Kaisha

 SII paid Rs 3000 crore for a 50% stake in the SCHOTT Kaisha from former co-owners Kairus Dadachanji and Shapoor Mistry.

5 drug companies riding the vax wave

Ever since the outbreak of Coronavirus, the Indian pharma industry has shown a recovery. It was one of the highperforming sectors of last year.

Lupin gets permit to make new TB drug

 The drug company has received a license to make the anti-TB drug pretomanid from non-profit drug developer, TB Alliance.

Legacy drug firm which sold 'Swadeshi' dysentery medication to Afghans waits and watches after Taliban takeover

The organization which was set up as a ‘Swadeshi enterprise’ meant to take on the stranglehold of British drug makers.

Antibiotic Overuse is Driving Drug Resistant Bacteria: ICMR

The research found a sustained increase in drug-resistant bacterias. This has resulted in medical doctors struggling to treat certain infections with medicines.